GSA Capital Partners’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $678K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8K | Sell |
|
|||||
|
2024
Q4 | $170K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $80K | Sell |
|
|||||
|
2023
Q3 | $361K | Sell |
|
|||||
|
2023
Q2 | $518K | Buy |
|
|||||
|
2023
Q1 | $449K | Sell |
|
|||||
|
2022
Q4 | $610K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $284K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $172K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $773K | Buy |
|
|||||
|
2019
Q3 | $280K | Buy |
|